Detalhe da pesquisa
1.
Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK).
Blood
; 120(24): 4706-11, 2012 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23047822